Franklin Biotechnology Discovery has an experienced team at the helm, but it needs to distinguish itself.
- NAV / 1-Day Return 117.43 / 3.36 %
- Total Assets 737.0 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.820%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 100,000
- Status Open
- TTM Yield 0.37%
- Turnover 24%
Morningstar’s Analysis FTDZX
Will FTDZX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
Process Pillar
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings 84
- Bond Holdings 1
- Other Holdings 5
- % Assets in Top 10 Holdings 50.9